申请人:Sankyo Company, Limited
公开号:US06005116A1
公开(公告)日:1999-12-21
Isoxazole compounds having the following general formula: ##STR1## wherein R.sup.1 represents an optionally substituted aryl group or aromatic heterocyclic group; R.sup.2 represents a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, a cyano group, a carboxyl group, an alkanoyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group; R.sup.3 represents an optionally substituted amino group or a saturated heterocyclic group; X represents an oxygen atom or a sulfur atom; and n is an integer of from 2 to 6. These compounds have excellent monoamine oxidase inhibitory activity and are useful as a therapeutic agent or a preventive agent against nervous diseases such as depression.
具有以下一般式的异噁唑化合物:##STR1## 其中 R.sup.1 代表可选取代的芳基或芳香杂环基;R.sup.2 代表氢原子、卤原子、可选取代的烷基、烯基、炔基、环烷基、环烯基、烷氧基、氰基、羧基、酰基、烷氧羰基或可选取代的氨基甲酰基;R.sup.3 代表可选取代的氨基或饱和杂环基;X 代表氧原子或硫原子;n 为2到6的整数。这些化合物具有出色的单胺氧化酶抑制活性,并可用作治疗剂或预防神经疾病如抑郁症的药物。